1. Home
  2. SCLX vs UCAR Comparison

SCLX vs UCAR Comparison

Compare SCLX & UCAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Scilex Holding Company

SCLX

Scilex Holding Company

N/A

Current Price

$4.90

Market Cap

35.2M

Sector

Health Care

ML Signal

N/A

Logo U Power Limited

UCAR

U Power Limited

N/A

Current Price

$3.76

Market Cap

35.5M

ML Signal

N/A

Company Overview

Basic Information
Metric
SCLX
UCAR
Founded
2011
2013
Country
United States
China
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Retail-Auto Dealers and Gas Stations
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
35.2M
35.5M
IPO Year
2020
2022

Fundamental Metrics

Financial Performance
Metric
SCLX
UCAR
Price
$4.90
$3.76
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$50.00
AVG Volume (30 Days)
36.4K
140.1K
Earning Date
04-10-2026
05-15-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$30,253,000.00
N/A
Revenue This Year
$122.52
N/A
Revenue Next Year
$186.30
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.20
$0.04
52 Week High
$34.27
$8.99

Technical Indicators

Market Signals
Indicator
SCLX
UCAR
Relative Strength Index (RSI) 27.24 58.13
Support Level $4.20 $0.89
Resistance Level $7.77 N/A
Average True Range (ATR) 0.30 0.66
MACD 0.01 0.41
Stochastic Oscillator 5.93 39.00

Price Performance

Historical Comparison
SCLX
UCAR

About SCLX Scilex Holding Company

Scilex Holding Co is focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain. It targets indications with high unmet needs and large market opportunities with non-opioid therapies for the treatment of patients with acute and chronic pain and are dedicated to advancing and improving patient outcomes. Its commercial products are: ZTlidoO for the relief of neuropathic pain associated with postherpetic neuralgia (PHN), which is a form of post-shingles nerve pain; ELYXYB, a potential first-line treatment ready-to-use oral solution for the acute treatment of migraine in adults and GLOPERBA, the liquid oral version of the anti-gout medicine colchicine indicated for the prophylaxis of painful gout flares in adults.

About UCAR U Power Limited

U Power Ltd is involved in the provision of vehicle sourcing services. It is principally engaged in the provision of new energy vehicles development and sales; battery swapping stations manufacturing and sales; battery swapping services, and sourcing services. The company, as a broker, engaged in sales of vehicles between automobile wholesalers and buyers, including small and medium-sized vehicle dealers and individual customers located in lower-tier cities in China.

Share on Social Networks: